ArticleInfection and drug resistance2019
Coproduction Of MCR-9 And NDM-1 By Colistin-Resistant
Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed.
- Potential dissemination of IncHI2/IncHI2A plasmids carryingMicrobiology spectrum · 2026Article
- Genotypic and Phenotypic Characterization ofMicroorganisms · 2026Article
- Co-occurrence of mcr-9 and blaCurrent microbiology · 2025Article
- Surveillance ofInternational journal of food science · 2025Article
- The multifaceted roles of phosphoethanolamine-modified lipopolysaccharides: from stress response and virulence to cationic antimicrobial resistance.Microbiology and molecular biology reviews : MMBR · 2024Review
- Polymyxin resistance in Enterobacter cloacae complex in Brazil: phenotypic and molecular characterization.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Mechanism for transmission and pathogenesis of carbapenem-resistant Enterobacterales harboring the carbapenemase IMP and clinical countermeasures.Microbiology spectrum · 2024Article
- Genomic investigation unveils high-risk ESBL producingCurrent research in microbial sciences · 2024Article
- Molecular epidemiology and genomic characterization of a plasmid-mediatedComputational and structural biotechnology journal · 2023Article
- More thanFrontiers in cellular and infection microbiology · 2023Article
- First report of coexistence ofFrontiers in microbiology · 2023Article
- Genomic and clinical characteristics of carbapenem-resistantFrontiers in microbiology · 2023Article
- Frequent convergence ofEmerging microbes & infections · 2022Article
- Genomic Epidemiology of Carbapenemase-Producing and Colistin-ResistantAntimicrobial agents and chemotherapy · 2022Article
- Occurrence and Characteristics ofMicrobiology spectrum · 2022Article
- Molecular characterization of NDM-1-producing carbapenem-resistantFrontiers in cellular and infection microbiology · 2022Article
- AFrontiers in cellular and infection microbiology · 2022Article
- Global epidemiology, genetic environment, risk factors and therapeutic prospects ofFrontiers in cellular and infection microbiology · 2022Review
- Molecular antibiotic resistance mechanisms and co-transmission of theFrontiers in microbiology · 2022Article
- Emergence of Neonatal Sepsis Caused by MCR-9- and NDM-1-Co-ProducingFrontiers in cellular and infection microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColistin acts as the last line of defense against severe infections caused by carbapenem-resistant PURPOSE: In this study, we reported the first clinical colistin and carbapenem-resistant
methodsBacterial antimicrobial susceptibility testing was performed using the broth microdilution method. Conjugation assay was carried out to investigate the transferability of
resultsConjugation assays revealed that both
conclusionThis study reveals the likelihood of a wide dissemination of this newly identified colistin resistance gene
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.